본문으로 건너뛰기
공식 EU 표시명용어집 항목 2780

AZELAIC ACID

이 기록은 EU 화장품 표시에 사용하는 공식 일반 원료 명칭을 확인해 줍니다. 그것만으로는 해당 물질이 허용되거나 제한이 없거나 안전하다는 것이 확인되지 않습니다.

글로벌 근거 요약

확인된 정체는 색인된 시장 데이터세트 13개 중 4개에서 일치하는 규제 근거가 있습니다: 국가 기록 4건과 EU 부속서 기록 0건. 모든 결과와 근거 부족 사항은 아래에 나열되어 있습니다.

근거가 있는 시장 4곳
확인한 시장
13
근거가 있는 시장
4
근거 부족
9
확인된 식별자
6

확인된 물질 정체

CAS:123-99-952457-54-2132499-85-517265-13-327825-99-6
EC:204-669-1
원료 색인 기록:
AZELAIC ACID
화장품 기능: BUFFERING, FRAGRANCE

Nonanedioic acid

일치 또는 보고된 명칭 5개
AZELAIC ACIDAzelaic acid and its saltsAzelaic acid1,7-헵탄디카르복실산(아젤라산), 그염류 및 유도체Azelaic Acid

13개 시장 전체의 규제 근거

일치하는 각 기록을 열어 범위, 농도, 조건, 경고 문구 및 공식 출처 버전을 확인하세요.

데이터세트 범위와 다음 조치를 보려면 가로로 스와이프하거나 스크롤하세요.

시장결과기록데이터세트의미 / 다음 조치
European Union
EU
일치하는 항목 없음0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
일치하는 항목 없음0
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.
Canada
CA
Restricted1기록 열기 1
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
연결된 모든 기록과 정확한 조건을 검토하세요.
New Zealand
NZ
일치하는 항목 없음0
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative.
ASEAN
ASEAN
Prohibited1기록 열기 1
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
연결된 모든 기록과 정확한 조건을 검토하세요.
China
CN
일치하는 항목 없음0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
일치하는 항목 없음0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
Prohibited1기록 열기 1
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
연결된 모든 기록과 정확한 조건을 검토하세요.
United States
US
일치하는 항목 없음0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
일치하는 항목 없음0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
일치하는 항목 없음0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
일치하는 항목 없음0
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
The standards are separate controlled publications; absence from a locally indexed excerpt is not permission.
Saudi Arabia
SA
Restricted1기록 열기 1
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
연결된 모든 기록과 정확한 조건을 검토하세요.
이 필터와 일치하는 시장 행이 없습니다.

일치하는 시장 기록 및 조건

화학적 정체 및 특성

CAS 123-99-9의 PubChem 2D 화학 구조
CAS 123-99-9PubChem CID 2266

Azelaic Acid

Nonanedioic acid is an alpha,-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. It has a role as an antibacterial agent, an antineoplastic agent, a dermatologic drug and a plant metabolite. It is a dicarboxylic fatty acid and an alpha,omega-dicarboxylic acid. It is a conjugate acid of an azelaate and an azelaate(2-). — ChEBI

IUPAC 명칭
nonanedioic acid
분자식
C9H16O4
분자량
188.22 g/mol
정확한 질량
188.10485899 Da
XLogP3
1.6
위상 극성 표면적
74.6 Ų
수소 결합 공여체
2
수소 결합 수용체
4
공유결합 단위
1
정의된 입체중심
0

다른 이름

FinaceaAnchoic acidLepargylic acid1,7-Heptanedicarboxylic acidAzelexSkinorenHeptanedicarboxylic acidEmerox 1110
보고된 명칭 16개 더 보기
1,9-Nonanedioic acidEmerox 1144n-Nonanedioic acidAcido azelaicoacide azelaiqueacidum azelaicumAzelaic acid, technical grade1,7-DicarboxyheptaneZK 62498ZK-62498Finacea FoamF2VW3D43YTNSC-19493CHEBI:481314-02-00-02055 (Beilstein Handbook Reference)hydron;nonanedioate
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

NIH PubChem PUG-View
식별자 정확히 일치2266

Attributed physical-property, hazard, environmental and use annotations.

  • Note: This chemical does not meet GHS hazard criteria for 6.5% (71 of 1087) of reports. 출처: European Chemicals Agency (ECHA)
  • Signal: Warning 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H315 (40.2%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (93.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1087 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 71 of 1087 reports by companies.; There are 11 notifications provided by 1016 of 1087 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
  • Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org 출처: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: The exact mechanism of action of azelaic acid is not known. It is thought that azelaic acid manifests its antibacterial effects by inhibiting the synthesis of cellular protein in anaerobic and aerobic bacteria, especially Staphylococcus epidermidis and Propionibacterium acnes. In aerobic bacteria, azelaic acid reversibly inhibits several oxidoreductive enzymes including tyrosinase, mitochondrial enzymes of the respiratory chain, thioredoxin reductase, 5-alpha-reductase, and DNA polymerases. In anaerobic bacteria, azelaic acid impedes glycolysis. Along with these actions, azelaic acid also improves acne vulgaris by normalizing the keratin process and decreasing microcomedo formation. Azelaic acid may be effective against both inflamed and noninflamed lesions. Specifically, azelaic acid reduces the thickness of the stratum corneum, shrinks keratohyalin granules by reducing the amount and distribution of filaggrin (a component of keratohyalin) in epidermal layers, and lowers the number of keratohyalin granules. 출처: Toxin and Toxin Target Database (T3DB)
  • Environmental Bioconcentration: An estimated BCF of 3 was calculated in fish for 1,7-heptanecarboxylic acid(SRC), using a log Kow of 1.57(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to have moderate mobility in soil(SRC). The pKa of 1,7-heptanecarboxylic acid is 4.55(4), indicating that this compound will exist almost entirely in the anion form in the environment and anions generally do not adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5). Volatilization from moist soil is not expected because the acid exists as an anion and anions do not volatilize. 1,7-Heptanecarboxylic acid is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 1.07X10-8 mm Hg(6). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(7). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to adsorb to suspended solids and sediment(SRC). A pKa of 4.55(4) indicates 1,7-heptanecarboxylic acid will exist almost entirely in the anion form at pH values of 5 to 9 and therefore volatilization from water surfaces is not expected to be an important fate process(5). According to a classification scheme(6), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(8). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), 1,7-heptanecarboxylic acid, which has a vapor pressure of 1.07X10-8 mm Hg at 25 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase 1,7-heptanecarboxylic acid is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 40 hrs(SRC), calculated from its rate constant of 9.8X10-12 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase 1,7-heptanecarboxylic acid may be removed from the air by wet or dry deposition(SRC). 1,7-Heptanecarboxylic acid does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Industry Uses: Monomers; Lubricating agent; Wetting agent (non-aqueous); Binder; Intermediate; Not Known or Reasonably Ascertainable; Corrosion inhibitor; Plasticizer 출처: EPA Chemical Data Reporting (CDR)
  • Cosmetic Ingredient Review Link: CIR ingredient: Azelaic Acid 출처: Cosmetic Ingredient Review (CIR)
  • Sources/Uses: Found in rancid oleic acid; [Merck Index] Used in organic syntheses, lacquers, alkyd resins, low-temperature plasticizers, adhesives, polyamides, urethane elastomers, and for the treatment of acne; [HSDB] Natural component of foods such as whole grain cereals and animal products; [REPROTOX] 출처: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Industrial Processes with risk of exposure: Painting (Pigments, Binders, and Biocides) [Category: Paint]; Working with Glues and Adhesives [Category: Other]; Plastic Composites Manufacturing [Category: Industry] 출처: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Azelaic acid is used in lacquers, alkyd resins, plasticizers, adhesives, polyamides, urethane elastomers, and organic syntheses. Azelaic acid is also used in treating of acne. 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: Organic synthesis, lacquers, product of hydrotropic salts, alkyd resins, polyamides, polyester adhesives, low-temperature plasticizers, urethane elastomers 출처: Hazardous Substances Data Bank (HSDB)
  • Uses: Use (kg; approx.) in Germany (2009): >1000; Consumption (g per capita; approx.) in Germany (2009): 0.0122; Calculated removal (%): 92.2 출처: NORMAN Suspect List Exchange
  • Uses: For the topical treatment of mild-to-moderate inflammatory acne vulgaris. 출처: Toxin and Toxin Target Database (T3DB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 132499-85-5의 PubChem 2D 화학 구조
CAS 132499-85-5CAS 17265-13-3PubChem CID 159815

Azelaic acid, disodium salt

IUPAC 명칭
disodium;nonanedioate
분자식
C9H14Na2O4
분자량
232.18 g/mol
정확한 질량
232.06874749 Da
위상 극성 표면적
80.3 Ų
수소 결합 공여체
0
수소 결합 수용체
4
공유결합 단위
3
정의된 입체중심
0

다른 이름

RefChem:135012Disodium azelateNonanedioic acid, disodium saltdisodium nonanedioateNonanedioic acid, sodium salt (1:2)0P4H8NH3UJUNII-0P4H8NH3UJsodium azelate
보고된 명칭 3개 더 보기
EINECS 241-298-4SODIUM AZELATE (2:1)DB-254558
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

CAS 52457-54-2의 PubChem 2D 화학 구조
CAS 52457-54-2PubChem CID 162680

Azelaic acid, dipotassium salt

IUPAC 명칭
dipotassium;nonanedioate
분자식
C9H14K2O4
분자량
264.40 g/mol
정확한 질량
264.01662189 Da
위상 극성 표면적
80.3 Ų
수소 결합 공여체
0
수소 결합 수용체
4
공유결합 단위
3
정의된 입체중심
0

다른 이름

RefChem:589030Dipotassium azelateAzelaic acid, potassium saltDipotassium nonanedioateNonanedioic acid, dipotassium saltNonanedioic acid, potassium salt (1:2)Nonanedioic acid, potassium saltPotassium nonanedioate
보고된 명칭 5개 더 보기
Potassium azelateEINECS 257-931-2UNII-C98170693JEINECS 243-190-2RTMGQVSGXYZVTE-UHFFFAOYSA-L
외부 데이터베이스 식별자

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

추가 공신력 있는 물질 조사

각 링크는 해당 출처에서 이 정체를 검색합니다. 링크는 조사 경로일 뿐이며, 그 출처에 정확히 일치하는 기록이 있다는 주장이 아닙니다. 각 출처의 성격과 법적 비중

이 기록 활용하기

처방에서 선별독립 비교 열기

공식 출처 및 범위

집행위원회 시행결정 (EU) 2025/1175(데이터세트 버전 EU 2025/1175)에서 가져왔습니다. 이 용어집은 제19조 제1항 (g)호에서 요구하는 성분 목록에 사용할 일반 원료 명칭을 제공하며, 승인 또는 안전성 목록이 아닙니다.

공식 결정 열기